Imidazole → (3R,4S)-4-Phenyl-3-[(triethylsilyl)oxy]azetidin-2-one
Reaktionsgleichung
[NH:1]1[CH2:4][CH2:3][C:2]1=[O:5].N1[CH:10]=[CH:9]N=C1.[CH2:11]([Si:13](Cl)([CH2:16][CH3:17])[CH2:14][CH3:15])[CH3:12].C(OCC)(=[O:21])C.[CH2:25]1[CH2:29]O[CH2:27][CH2:26]1>>[C:10]1([C@@H:4]2[NH:1][C:2](=[O:5])[C@@H:3]2[O:21][Si:13]([CH2:16][CH3:17])([CH2:14][CH3:15])[CH2:11][CH3:12])[CH:9]=[CH:27][CH:26]=[CH:25][CH:29]=1Komponenten
6
Versuchsvorschrift
To azetidinone LXXI (580 mg, 3.55 mmol) in dry THF (5.0 mL) was added imidazole (265.5 mg, 3.90 mmol), followed by triethylsilyl chloride (TESCl, 0.654 mL, 3.90 mmol). The mixture was allowed to be stirred for 1 h. Ethyl acetate was added and the organic layer was washed with brine, 10% aqueous HCl and dried. Silica gel chromatography (being eluted with 25% ethyl acetate in hexane) gave 670 mg (Y: 68%) of compound LXXII as a foam.
Aufarbeitung
- washthe organic layer was washed with brine, 10% aqueous HCl
- customdried
- washSilica gel chromatography (being eluted with 25% ethyl acetate in hexane)
- customgave 670 mg (Y: 68%) of compound LXXII as a foam
Quellen und Nachweise
- ORD-Eintrag
- ord-f4989d7c15c64ddf8f0593550af48222
- Quelldatensatz
- uspto-grants-1993_12
- Patentnummer
- US05272171
Notizen zur Reaktion
Wird geladen…